{"title": "COVID-19 Funding", "author": null, "url": "https://research.ucdenver.edu/research-development-and-education/home/funding/covid-19-funding", "hostname": "ucdenver.edu", "description": null, "sitename": "research.ucdenver.edu", "date": "2021-08-23", "cleaned_text": "funding mechanism; this SEN expires March 15, 2023 |Agency for Healthcare Research and Quality (AHRQ)|[Special Emphasis Notice (SEN): AHRQ Announces Interest in Health Services Research to Address Substance Use Disorder Epidemic (NOT-HS-21-010)](https://grants.nih.gov/grants/guide/notice-files/NOT-HS-21-010.html) |AHRQ is offering an opportunity for health services researchers to propose research projects addressing the US substance use disorder crisis. Within this context, AHRQ is very interested in receiving applications that use the current COVID-19 pandemic as a natural experiment to discover how COVID-19 related changes in health care delivery (e.g., increase in telehealth usage) affected access to care, quality of care and health inequities. Multiple grant mechanisms are offered.| |December 31, 2021||Amazon Web Services (AWS)|[AWS Diagnostic Development Initiative (DDI)](https://aws.amazon.com/government-education/nonprofits/disaster-response/diagnostic-dev-initiative/) |The program purpose is to accelerate research and innovation to advance understanding and detection of COVID-19 and other infectious diseases to better mitigate current and future outbreaks. There are currently four program areas: 1) Early Disease Detection, 2) Diagnostics, 3) prognosis and 4) Public Health Genomics. AWS provides AWS Promotional Credits and technical expertise to support use of AWS services. | |September 23, 2021 for required Letters of Intent; invited full applications will be due December 16, 2021||American Lung Association (ALA)|[COVID-19 and Emerging Respiratory Viruses Research Awards](https://www.lung.org/research/awards-and-grants-opportunities) |ALA will support clinical, basic, translational and population health research projects related to emerging respiratory pathogens like SARS-CoV-2. | |September 30, 2021 for required Letters of Intent; invited full applications then due December 15, 2021||American Occupational Therapy Foundation|[Intervention Research Grants](https://www.aotf.org/Grants/Intervention-Research-Grant) |The Foundation is particularly interested in projects that would study the impact of the COVID-19 pandemic on daily life by addressing questions of importance within the scope of occupational therapy.| |Continuous submission||Argonne National Laboratory (US Department of Energy)|[Expedited, Rapid Access Call for COVID-19 Research Support](https://www.aps.anl.gov/Users-Information/covid19/proposal) |The Advanced Photon Source at Argonne is offering remote access to beamlines for macromolecular crystallography and BioSAXS for research efforts related COVID-19.| |September 1, 2021||Association of Black Cardiologists (ABC)||2022 ABC COVID-19 Innovation Awards||The sponsor is seeking to identify solution-focused mechanisms aimed at preventing the spread of COVID-19 infection and decreasing cardiovascular and other health risks due to COVID-19. Priority areas are 1) Development of targeted interventions/approaches aimed at addressing vaccine uptake and long-hauler syndrome, especially in Black, Hispanic/LatinX or Native communities, 2) implementation of sustainable mechanisms to prevention infection spread, 3) projects that leverage partnerships with community-facing organizations and 4) proposals that incorporate access to quality healthcare.| |No deadline specified||Boehringer Ingelheim||Investigator-Initiated Studies (IIS): Established Products||The sponsor's purpose is to evaluate potential clinical and non-clinical investigations involving COVID-19 related matters including safety, clinical outcomes, antiviral effects or antithrombotic benefits.| |Continuous submission||Brookhaven National Laboratory (US Department of Energy)|[COVID-19 Research Support](https://www.bnl.gov/ps/) |The Center for Biomolecular Structure is supporting macromolecular crystallography experiments at the AMX and FMX beamlines and solution scattering experiments at the LiX beamline for COVID-19 research.| |Applications accepted on a rolling basis (open until sponsor meets program goals)||CISCO Systems, Inc.|[Contactless Supply Chain (RFP-21-06)](https://research.cisco.com/research-grants/RFP-21-06) |Noting that COVID-19 among other factors has placed emphasis on the need for profound transformation of supply chains, CISCO welcomes both technical and business-related projects.| |Proposals may be submitted any time; note that interested researchers should respond quickly as Cisco withdraws RFPs when they determine they have met the program goal.||CISCO Systems, Inc.|[Future of Work (RFP-21-02)](https://research.cisco.com/research-grants/RFP-21-02) |In light of COVID-19 and the new reality of working from home indefinitely that the pandemic has brought us, Cisco Research Center has released this RFP to encourage research aimed at making the remote work environment more ideal.| |Continuous submission until closed by sponsor||CISCO Systems, Inc.| [Tech for Healthcare (RFP-21-04)](https://research.cisco.com/research-grants/RFP-21-04) |Cisco is interested in funding research related to applications of technology for health care purposes. Pandemic related sponsor interests include sensor technologies, scalable monitoring of public health protocols such as mask wearing, systems for scalable contact tracing and many others.| |EOIs for the BPBC competition are due October 1, 2021 and full applications will then be invited||Coalition for Epidemic Preparedness Innovations (CEPI)|[New Broadly Protective Betacoronavirus Candidate Vaccines (BPBC)](https://cepi.net/get_involved/cfps/) This opportunity offers funding for vaccine development related to a broadly protective Betacoronavirus (BPBC) vaccine. Note at least one of the partners within a consortium must have experience in human vaccine development and a track record of brining vaccine candidates through to human clinical trials within the last 5 years. |Applications accepted anytime until funds are depleted for the year||Comcast|[Innovation Fund: Research Grants](https://innovationfund.comcast.com/) |Comcast is interested in receiving proposals related to COVID-19 effects on the Internet among other topics.| Exploration-Hypothesis Development Award and Investigator-Initiated Research Award mechanisms: June 30, 2021 for pre-applications; invited full applications due October 1, 2021 Early Investigator Research Award mechanism: September 7, 2021 for letters of intent with full applications then due October 1, 2021 |Congressionally Directed Medical Research Program (CDMRP)|[DOD Multiple Sclerosis Research Program](https://cdmrp.army.mil/funding/msrp) |CDMRP has released program details for three funding mechanisms - the Early Investigator Research Award (targeting postdoctoral and clinical fellows), the Exploration-Hypothesis Development Award and the Investigator-Initiated Research Award - that will support research on the interactions between multiple sclerosis and COVID-19.| |Applications accepted on rolling basis||COVID-19 Early Treatment Fund (CETF)|[Grants Program](http://www.treatearly.org/apply-for-funding) |Advocating early, effective treatment for COVID-19 patients designed to prevent hospitalization, CETF is supporting outpatient clinical trials of re-purposed antiviral drugs. | |September 17, 2021||CURE Epilepsy|[Epilepsy Research Continuity Fund (ERCF)](https://www.cureepilepsy.org/grants-program/) |CURE Epilepsy will reimburse epilepsy researchers for expenses due to institutional shutdowns during the COVID-19 pandemic for which institutional support was not available. Priority will be given to current and previous CURE Epilepsy grantees. An eligible applicant is an early-stage career investigator who has a current epilepsy-focused grant of at least $100,000, providing up to 5 years of support and approved after January 1, 2018.| |Continuous submission||Department of Energy | (US DOE) [Dear Colleague Letter - Corona Virus Disease 2019 (COVID-19)](https://science.osti.gov/-/media/sc-1/pdf/COVID-19-letter.pdf?la=en&hash=2A142317F56F185FC3E2CEF0AEAD6CACB3E70C7F) |DOE is encouraging submission of scientific questions that underpin COVID-19 response and that the research community may answer using DOE user facilities, computational resources, and enabling infrastructure.| |Continuous submission||Department of Energy (DOE)||Rapid Access for COVID-19 Research||DOE is offering remote access to advanced user facilities to support research into the COVID-19 virus and the search for effective diagnostics and therapeutics.| October 31, 2021 (this is final white paper submission deadline; full proposals will be invited by the sponsor) |Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA)||Broad Agency Announcement (BAA)||BARDA has updated this BAA (Amendment # 25) to reflect its current Areas of Interest (AOI), all related to COVID-19: | AOI 7.7.1 Diagnostic assay for detection (SARS-CoV-2 infection), Including Serology Tests AOI 7.7.5 Screening Tests at Point of Care (2-minute Time to Result) BAA is in effect until February 3, 2023 Abstracts accepted until rescinded for AOI #2 and AOI #6 Abstracts accepted through February 3, 2023 for AOI #8 and AOI #9 Abstracts accepted through November 30, 2021 for AOI #10 Abstracts accepted through January 15, 2022 for AOI #11a&b |Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA)| Division of Research Innovations and Ventures Easy Broad Agency Announcement (DRIVe) See DRIVe EZ BAA Special Instructions 014 for details on AOI #8, #9, #10, #11a&b An update from 08/23/21 indicates BARDA has made the following changes to their Areas of Interest (AOIs): Closed AOI #1 - Early Notification to Act, Control Treat (ENACT) Paused AOI #7: ImmuneChip+ Added: AOI #8: Bringing Laboratory Testing to the Home AOI #9: Digital Health Tools for Pandemic Preparedness AOI #10: Next Generation Sequencing (NGS)-based Pathogens Diagnostics for the #11b: Enabling Technologies to Support Home-Based Diagnostics for SARS-CoV-2 Acute Infection Still in Effect: AOI #2 - Infection Severity and Solving Sepsis AOI #6 - Beyond the Needle |Continuous Submission||Diamond for Proposals: SARS-CoV-2](https://www.diamond.ac.uk/Instruments/Mx/Fragment-Screening.html#) |Diamond, the UK's national synchotron, is offering its facilities and fragment screening expertise to researchers world-wide who are working on COVID-19 related projects.| |Applications accepted on rolling basis||Emergent Ventures|[Fast Grants for COVID-19](https://www.mercatus.org/emergent-ventures) |The sponsor provides funding for researchers at academic institutions who are currently working on scientific or biomedical COVID-19 projects that could help with the pandemic within the next 6 months. Funding decisions are promised within 14 days for this second round of funding. This grant program is administered by the Mercatus Center at George Mason University.| |September 10, 2021||Environmental Protection Agency (EPA)|[Children's Healthy Learning Environments in Low-Income and/or Minority Communities (EPA-OCHP-21-01)](https://www.grants.gov/view-opportunity.html?oppId=334805) |This program provides funding for capacity-building projects that help school communities understand and address local environmental and public health issues that affect children. Projects should address health outcome disparities from pollution and/or the COVID-19 pandemic.| |Applications accepted on a rolling basis||Euro Bio-Imaging|[Fast Track Access to Biological and Biomedical Imaging Technologies for COVID-19 Research Projects](https://www.eurobioimaging.eu/content/Covid19) |Scientists worldwide with ongoing COVID-19 research projects in need of imaging resources will want to consider this opportunity. The sponsor is offering to facilitate access to over 40 biological and biomedical imaging technologies, supporting basic research efforts as well as medical applications and diagnostics.| |Continuous submission||Extreme Science and Engineering Discovery Environment (XSEDE)| (funded by the National Science Foundation) [COVID-19 HPC Consortium](https://www.xsede.org/covid19-hpc-consortium) This Consortium houses some of the most powerful and advanced computers in the world which will be made available to researchers around the world to accelerate understanding of the COVID-19 virus and the development of treatments and vaccines to help address infections. |No deadline||Facebook|[CrowdTangle Public Application for Academics](https://research.fb.com/blog/2020/07/crowdtangle-opens-public-application-for-academics/) |Using Facebook's CrowdTangle, designed to enhance abilities to follow, analyze and report on what's happening across social media, this opportunity will allow researchers to gain access to CrowdTangle tools/technical support. Projects should be focused on misinformation, elections, COVID-19, racial justice and/or well-being. Applications are for access to CrowdSource; no funding is associated with this opportunity.| |No deadlines||Facebook|[New Preventive Health Survey Data Available for Research](https://dataforgood.fb.com/docs/preventive-health-survey-request-for-data-access/) |Facebook has partnered with the Massachusetts Institute for Technology (MIT) Initiative on the Digital Economy and Johns Hopkins University Center for Communication Programs to launch a Preventive Health Survey, designed to assess the public's knowledge, attitude and practices about COVID-19 prevention. Researchers are invited to request aggregated, de-identified survey data; access to microdata may also be requested but requires a signed data use agreement.| |None indicated||Facebook|[Symptom Surveys](https://research.fb.com/blog/2020/05/expanding-support-for-covid-19-research-through-the-symptom-surveys/) |Facebook is offering access to survey data collected on a national and global level concerning Facebook users and COVID-19 symptoms. The Symptom Survey datasets are managed by Carnegie Mellon University and the University of Maryland. Academic and non-profit researchers may request access to the aggregated survey data. See the website for more details on survey methodology and the process for requesting data access.| |Submissions will be uploaded on the FIND website on a rolling basis||Foundation for Innovative New Diagnostics (FIND)|[Open Call for Data - COVID-19](https://www.finddx.org/wp-content/uploads/2020/03/COVID-19_Dx-performance-data-sharing_FINAL-27.03.2020.pdf) This Switzerland-based non-profit is asking laboratories around the world with any performance data on commercially available in vitro diagnostic tests that detect nucleic acid, viral antigen or antibodies to contribute to a centralized collection of data as a global public good. The data compilation will be made available on the FIND website to enable fast data sharing throughout the diagnostic community. |No deadline indicated||Ginkgo Bioworks|[Access to Platform for Partner COVID-19 Projects](https://www.ginkgobioworks.com/covid-19/) |The sponsor is offering access to its platform for company and academic labs engaged in developing a diagnostic, drug or vaccine to stop COVID-19.| |Ongoing review| William T. Grant Foundation Spencer Foundation [Rapid Response Research Grants](http://wtgrantfoundation.org/william-t-grant-and-spencer-foundations-award-rapid-response-research-grants-to-combat-youth-inequality-exacerbated-by-the-covid-19-pandemic) |The Grant Foundation will use the Rapid Response Research Grants mechanism to fund projects designed to combat youth inequality in the US, a main priority of the Foundation, made worse by the COVID-19 Pandemic. They are joined by the Spencer Foundation in this endeavor. These grants will fund collaborations between researchers and policymakers. Researchers on the team synthesize relevant literature within 6-8 weeks from the start of the grant award, and work with their policy partners to ensure the research results in actions benefiting youth.| |September 17, 2021||International Telecommunications Union (ITU) (United Nations)|[Connect2Recover Research Competition](https://www.itu.int/en/ITU-D/Pages/connect2recover/research-competition/default.aspx) |The sponsor seeks research proposals to accelerate digital inclusion during the COVID-19 recovery period globally. Specific competition goals are to: 1) improve research focus on digital resiliency and digital inclusion, 2) build a global research community around digital inclusion and 3) promote knowledge sharing that informs targeted practices to build back better with broadband. Partnerships between institutions in developed and developing countries are encouraged.| |Phase 1 Brief Proposals may be submitted anytime; full proposals will be invited by the sponsor||Robert Wood Johnson Foundation (RWJF)|[Pioneering Ideas: Exploring the Future to Build a Culture of Health](https://www.rwjf.org/en/library/funding-opportunities/2020/pioneering-ideas-2020-exploring-the-future-to-build-a-culture-of-health.html?rid=0034400001rm5FuAAI&et_cid=2046258) |RWJF is looking for future-focused projects in four focus areas to benefit their overall Foundation theme - Building a Culture of Health: 1) Future of Evidence, 2) Future of Social Interaction, 3) Future of Food and 4) Future of Work. Emphasis is on health equity. The sponsor notes that while this opportunity is focused on broader trends evolving prior to COVID-19, they are open to projects addressing the pandemic, either directly or indirectly.| |Two-step application process begins with Brief Proposals, due June 28, 2021; invited full applications then due November 1, 2021||Robert Wood Johnson Foundation (RWJF)|[Research in Transforming Health and Health Care Systems: Understanding the Impact of Medicaid Policy Changes in Response to the COVID-19 Pandemic and Structural Racism](https://www.rwjf.org/en/library/funding-opportunities/2021/research-in-transforming-health-and-health-care-systems.html?rid=0034400001rm5FuAAI&et_cid=2453106) |RWJF will fund projects that evaluate or predict the effects of Medicaid policy changes enacted as a result of the COVID-19 pandemic, specifically examining the impact of Medicaid policies on communities of color and/or exploring how current or proposed policies may alleviate or exacerbate racial inequity and structural racism in the context of Medicaid.| |September 10, 2021||March of Dimes (MOD)||Research Grants||MOD supports research involving translational and actionable science leading directly to interventions or preventions related to advancing health for mothers and babies. Priority areas are Pregnancy-Related Disorders, Developmental Origins of Infant Health, and Maternal Morbidity and Mortality. The sponsor indicates proposed research may include continued investigations into the effects of COVID-19 infections on maternal and infant health.| |September 3, 2021 for required pre-proposals; full proposals will be invited by the sponsor||Marketing Science Institute|[Learning from Disruption: New Connections, New Directions post-COVID](https://www.msi.org/research/msi-research-competition-and-call-for-proposals/) |The sponsor asks which societal changes brought about by the COVID-19 pandemic will persist? Three specific areas are targeted: Supply chain changes, lifestyle changes and associated changes in consumption patterns, and effects of politics and social change on marketing.| |Continuous submission (contact program officer first)||National Cancer Institute (NCI)|[Notice of Information: Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-Supported Projects to be Redirected to COVID-1-Related Research during the Crisis](https://grants.nih.gov/grants/guide/notice-files/NOT-CA-20-054.html) |NCI-funded researchers who wish to be able to contribute their expertise and resources toward a better understanding of the impacts of SARS-CoV-2 infection and COVID-19 disease on cancer patients' disease progression, response to therapy, care delivery, or survivorship may request variance to use a portion of their NCI project funds to address this crisis.| |Applications accepted on a rolling basis from May 15, 2020 through January 25, 2022||National Center for Advancing Translational Sciences (NCATS)|[Notice of Special Interest regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus](https://grants.nih.gov/grants/guide/notice-files/NOT-TR-20-016.html) |NCATS is interested in research in the use of microphysiological systems or tissue chips in collecting and examining data on the risks and outcomes for COVID-19 infection, and then advance the translation of research findings into diagnostics, therapeutics, and vaccines.| |Applications accepted on rolling basis from May 15, 2020 to January 25, 2022||National Center for Advancing Translational Sciences (NCATS)|[Notice of Special Interest regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus](https://grants.nih.gov/grants/guide/notice-files/NOT-TR-20-017.html) |NCATS is interested in three specific topics: 1) Incorporation of new and emerging data related to SARS-CoV-2 into ongoing research efforts to develop microphysiological systems/tissue chips models for COVID-19; 2) Use of microphysiological systems/tissue chips or evaluating, repurposing or modification of diagnostic tools to enable rapid detection of COVID-19 infection; and 3) Use of microphysiological systems/tissue chips for the rapid development and assessment of potential therapeutic agents for COVID-19| |Applications are due beginning with the October 5, 2020 deadline; this NOSI will expire July 6, 2024||National Heart, Lung and Blood Institute (NHLBI)|[Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI) (NOT-HL-20-814)](https://grants.nih.gov/grants/guide/notice-files/NOT-HL-20-814.html) |NHLBI will accept applications for R01 projects designed to gain a better understanding of host resilience as a critical determinant of outcomes in acute respiratory distress syndrome/acute lung injury.| |October 22, 2021||National Institute of Allergy and Infectious Diseases (NIAID)|[Emergency Awards: Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern (U19 Clinical Trial Not Allowed) (RFA-AI-21-050)](https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-050.html) |NIAID wishes to establish a program of multidisciplinary research centers focused on discovery and development of new antiviral drug candidates. These Centers will focus on SARS-CoV-2 and other coronaviruses involved in historical or future outbreaks as well as one or more additional priority RNA viruses. Virus families of interest are Paramyxoviruses, Bunyaviruses, Togaviruses, Filoviruses, Picornaviruses and Flaviviruses.| |NOSI expires 2023||National Institute of Allergy and Infectious Diseases (NIAID)|[Notice of Special Interest (NOSI): Complement in Basic Immunology (CIBI) (NOT-AI-21-008)](https://grants.nih.gov/grants/guide/notice-files/NOT-AI-21-008.html) |NIAID will support studies that accelerate understanding of the roles of complement components and/or receptors in the initiation, magnitude, maintenance and quality of immune responses against infectious agents including SARS-CoV-2. The ultimate goal of this knowledge will be to inform development of adjuvants and vaccine candidates or therapeutics that target complement components.| |Deadlines vary by funding mechanism; this Notice expires September 8, 2021.||National Institute of Allergy and Infectious Diseases (NIAID)|[Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)](https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-051.html) |Research areas are: Studies to understand critical aspects of viral infection, replication, pathogenesis and transmission; Studies on the evolution and emergence of SARS-CoV-2 viruses; Development of diagnostic tests; Development of SARS-CoV-2 therapeutic candidates; Identification and evaluation of the innate, cellular and humoral immune responses to SARS-CoV-2 infection; and Development of SARS-CoV-2 vaccine candidates. NIAID will be using the Small Grant (R03), SBIR and STTR funding mechanisms.| March 15, 2022 |National Institute of Allergy and Infectious Diseases (NIAID)|[Research on Bat Immunology (R21 Clinical Trial Not Allowed) (PAR-21-184)](https://grants.nih.gov/grants/guide/pa-files/PAR-21-184.html) |Noting the societal impact of the SARS-CoV-2 pandemic and the possibility of future pandemics, NIAID is seeking applications to characterize the bat immune system.| |Deadlines start September 7, 2021; this NOSI expires May 8, 2024| National Institute of Allergy and Infectious Diseases (NIAID) National Institute on Drug Abuse (NIDA) National Institute of Mental Health (NIMH) [Notice of Special Interest (NOSI) - HIV/AIDS in the Era of COVID-19: When Pandemics Collide (NOT-AI-21-057)](https://grants.nih.gov/grants/guide/notice-files/NOT-AI-21-057.html) |The Institutes are seeking applications for epidemiology investigations to quantify the impact of the COVID-19 pandemic on Human Immunodeficiency Virus (HIV) prevention, incidence, transmission and outcomes. Both R01 and R21 applications will be accepted.| |Standard NIH deadline schedule applies, depending on funding mechanism selected; NOSI expires November 19, 2021||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|[Notice of Special Interest (NOSI): Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases (NOT-AR-21-012)](https://grants.nih.gov/grants/guide/notice-files/NOT-AR-21-012.html) |NIAMS will support basic, translational, pre-clinical and clinical observational research focused on COVID-19 and its intersection with rheumatic, musculoskeletal and skin diseases/conditions. Specific interests include impact of vaccination on patients with underlying diseases within the NIAMS mission, long-term disease consequences and health disparities.| |Proposals may be submitted anytime until further notice; proposal review is promised within one week||National Institute of Biomedical Imaging and Bioengineering (NIBIB)|[Fast-Track Program for COVID-19 Test Development and Distribution - Rapid Acceleration of Diagnostics (RADx)](https://www.poctrn.org/radx) |The goal of this program is to enable rapid production of innovative SARS-CoV-2 diagnostic tests. Both early and advanced stage projects will be supported.| |November 29, 2021 with optional letters of intent due October 29, 2021||National Institute of Child Health and Human Development (NICHD)|[Impact of Technology and Digital Media (TDM) Exposure/Usage on Child and Adolescent Development (P01 Clinical Trial Optional) (RFA-HD-22-009)](https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-22-009.html) |NICHD is interested in supporting projects examining pathways by which technology and digital media (TDM) exposure and usage affect developmental trajectories and health outcomes in early childhood and adolescence. Funding will be provided through the Program Project (P01) mechanism focused on integrated, multi-project research programs. Both existing and new collaborations will be considered. Applicants should plan to address the cohort effect in relation to the COVID-19 pandemic that will likely be detectable during and after the pandemic.| |October 5, 2021; February 5, 2022; October 5, 2022; February 5, 2023; October 5, 2023; February 5, 2024; October 5, 2024| National Institute of Child Health and Human Development (NICHD) National Institute of Environmental Health Sciences (NIEHS) National Institute of Allergy and Infectious Diseases (NIAID) [Pediatric Immune System - Ontogeny and Development (R01 Clinical Trial Not Allowed) (PAR-21-248)](https://grants.nih.gov/grants/guide/pa-files/PAR-21-248.html) |NICHD will support studies to correlate immune system and development patterns between two or more age groups - neonates, infants, and children and adolescents - and further understand impact of infectious diseases, microbiome and environmental factors on the ontogeny and development of the pediatric immune system. Focus of impact is during pregnancy and the post-natal period. Topics of interest include response to infectious diseases including SARS-CoV-2.| |First deadline is September 15, 2021; NOSI expires May 8, 2022||National Institute of Child Health and Human Development (NICHD)|[Notice of Special Interest (NOSI): Competitive Revision and Administrative Supplements to Existing NICHD HIV Grants and Cooperative Agreements to Understand HIV Health Impacts of COVID-19 (NOT-HD-21-037)](https://grants.nih.gov/grants/guide/notice-files/NOT-HD-21-037.html) |Principal Investigators with current HIV funding from NICHD may request additional funding for studies to increase understanding of the consequences of COVID-19 in populations central to the Institute's mission. Populations of interest include pregnant, post-partum and lactating women; infants, children, adolescents and young adults; people with intellectual and developmental disabilities and individuals with physical disabilities or mobility impairments.| |Standard NIH deadlines for R01 and R21 grant mechanisms through July 16, 2023||National Institute of Child Health and Human Development (NICHD)|[Notice of Special Interest (NOSI): Emerging Viral Infections and their Impact on the Male and Female Reproductive Tract (NOT-HD-20-021)](https://grants.nih.gov/grants/guide/notice-files/NOT-HD-20-021.html) |NICHD is looking for cutting edge research to investigate possible effects of emerging viruses including SARS-CoV-2 on reproductive tissues and cells to better understand potential impacts in fertility that may be sex specific. Investigators may submit for Research Project (R01) or Exploratory/Developmental Research (R21) Grants.| |Deadlines start in September, 2021, depending on chosen funding mechanism; the NOSI expires September 8, 2024||National Institute of Child Health and Human Development (NICHD)|[Notice of Special Interest (NOSI): Promoting Vaccine Access, Acceptance and Uptake among Children, Adolescents, Pregnant and Lactating Women and Persons with Disabilities (NOT-HD-21-038)](https://grants.nih.gov/grants/guide/notice-files/NOT-HD-21-038.html) |NICHD is seeking applications to identify best approaches to reducing barriers to vaccine access, acceptance and uptake among their priority populations. They will support intervention research, community-engaged research, research focused on how social determinants of health may exacerbate or mitigate vaccine acceptance, studies of more effective communication techniques and more.| |Deadlines dependent on chosen grant mechanism; this NOSI expires May 8, 2024||National Institute of Child Health and Human Development (NICHD)|[Notice of Special Interest (NOSI): Research on the Impact of the COVID-19 Pandemic and Risks for Abuse and Injury among Vulnerable Children and Youth (NOT-HD-21-026)](https://grants.nih.gov/grants/guide/notice-files/NOT-HD-21-026.html) |Studies exploring the relationship between the COVID-19 pandemic and the potential for increased and/or undetected child abuse situations will be supported. Research Project Grants (R01), Small Grants (R03) and Exploratory/Developmental Research Grants (R21) are all offered.| |Deadlines dependent on chosen grant mechanism; this NOSI expires March 8, 2023.||National Institute of Child Health and Human Development (NICHD)|[Notice of Special Interest: Research on Rehabilitation Needs Associated with the COVID-19 Pandemic (NOT-HD-20-031)](https://grants.nih.gov/grants/guide/notice-files/NOT-HD-20-031.html) |NICHD wishes to fund research addressing the rehabilitation needs of COVID-19 survivors; better understand the impact of disruptions to rehabilitation services caused by COVID-19; and understand the social, behavioral, economic and health impacts of the COVID-19 pandemic on people with physical disabilities. Applications do not have to address all three research interests.| |The NOSI expires May 8, 2023.||National Institute of Dental and Craniofacial Research (NIDCR)|[Notice of Special Interest (NOSI): NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19) (NOT-DE-21-001)](https://grants.nih.gov/grants/guide/notice-files/NOT-DE-21-001.html) |NIDCR will support studies focused on the role of oral/nasal cavity and oral manifestations related to SARS0CoV-2 and/or COVID-19 within the Institute's mission.| |Applications accepted on rolling basis between March 15, 2021 and December 15, 2021||National Institute of General Medical Sciences (NIGMS)|[Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Modeling Research on Coronavirus 2019 (COVID-19) and the Causative Virus SARS-CoV-2 (NOT-GM-21-019)](https://grants.nih.gov/grants/guide/notice-files/NOT-GM-21-019.html) |This opportunity is available to all NIGMS-funded investigators to address one research area: Incorporation of data related to SARS-CoV-2 into ongoing research efforts to develop predictive computational models for the spread of SARS-CoV-2 and other related infectious agents.| |Applications will be accepted on a rolling basis through June 1, 2023||National Institute of Mental Health (NIMH)|[Notice of Special Interest (NOSI): Administrative Supplements for COVID-19 Impacted NIMH Research (NOT-MH-21-120)](https://grants.nih.gov/grants/guide/notice-files/NOT-MH-21-120.html) |NIMH will provide administrative supplements to cover unanticipated costs caused by the COVID-19 pandemic. Note that the sponsor will not support COVID-related research through this NOSI.| |Not applicable||National Institute of Mental Health (NIMH)|[Notice Announcing the Availability of Common Data Elements for Research Related to the Public Health Emergency Caused by Coronavirus 2019 (COVID-19) (NOT-MH-20-061)](https://grants.nih.gov/grants/guide/notice-files/not-mh-20-061.html) |With the overall goal of more effective human subjects data harmonization, NIMH is offering guidance on the use of consensus-derived common data elements (CDEs) pertaining to mental health outcomes including a set of newly available measures regarding experiences during the COVID-19 public health emergency and exposures to the SARS-CoV-2 virus.| |NOSI expires September 8, 2022| National Institute of Mental Health (NIMH) Other Participating Institutes: National Institute of Child Health and Human Development (NICHD) [Notice of Special Interest: COVID-19 Related School Disruptions Impact on Mental Health, Cognitive, Social and Emotional Development of Children (NOT-MH-21-225)](https://grants.nih.gov/grants/guide/notice-files/NOT-MH-21-225.html) |The impact of \"primary instructional setting disruptions\" due to the COVID-19 pandemic on the development of children is the major focus of this NOSI. Research project grants (R01) are being offered. Pre-school and early childhood education settings and school-aged children (ages 3-12) are the target groups. Additionally, NICHD is specifically interested in COVID-19 related research on vulnerable populations.| |October 5, 2021 (first deadline; NOSI expires September 8, 2024)| National Institute of Mental Health Other Participating NIH Components: National Eye Institute (NEI) National Institute on Aging (NIA) National Institute on Alcohol Abuse and Alcoholism (NIAAA) National Institute of Child Health and Human Development (NICHD) National Institute on Deafness and Other Communication Disorders (NIDCD) National Institute of Dental and Craniofacial Research (NIDCR) National Institute on Drug Abuse (NIDA) National Institute of Nursing Research (NINR) National Institute on Minority Health and Health Disparities (NIMHD) National Center for Complementary and Integrative Health (NCCIH) [Notice of Special Interest (NOSI): Social, Behavioral and Economic Impact of COVID-19 in Underserved and Vulnerable Populations (NOT-MH-21-330)](https://grants.nih.gov/grants/guide/notice-files/NOT-MH-21-330.html) |Through this NOSI, the sponsors are interested in funding research related to 1) the roles and impacts of interventions (digital health, community-engaged and multi-level) on COVID-19 and 2) the leveraging of existing large-scale data sources to improve prediction concerning effects of mitigation efforts (masking, social distancing, vaccinations) on COVID-19 - all with an emphasis on underserved and vulnerable populations.| |The NOSI opens on March 4, 2021 and expires on May 8, 2023.||National Institute on Aging (NIA)|[Notice of Special Interest (NOSI): Aging-Relevant Behavioral and Social Research on Coronavirus Disease 2019 (COVID-19) (NOT-AG-21-015)](https://grants.nih.gov/grants/guide/notice-files/NOT-AG-21-015.html) |NIA is interested in research to improve understanding of the behavioral, social and economic effects of the pandemic and to enhance efforts to control its spread. | |Dependent on grant mechanism chosen; NOSI expires May 7, 2023||National Institute on Aging (NIA)|[Notice of Special Interest (NOSI): Neurological and Neurocognitive Sequelae from SARS-CoV-2 Infection and COVID-19 Aging Research Project (R01), Small (R03) and Exploratory/Developmental (R21) research grant mechanisms, NIA seeks applications addressing a variety of topics including: neurological/neurocognitive symptoms of SARS-CoV-2 infection in older adults (e.g., delirium); role of brain barriers in protecting neural tissue and how barriers are compromised by the virus; neurobiology of COVID-19 pathophysiology (e.g., vascular development; devices and wearables that can detect neurocognitive changes in older adults after recovery from COVID-19.| |Deadlines dependent on chosen grant mechanism; the NOSI expires on September 8, 2024| National Institute on Alcohol Abuse and Alcoholism (NIAAA) Other Participating Components: National Institute on Drug Abuse (NIDA) National Cancer Institute (NCI) [Notice of Special interest (NOSI): Public Policy Effects on Alcohol-, Cannabis-, Tobacco-, and Behaviors and Outcomes (NOT-AA-21-028)](https://grants.nih.gov/grants/guide/notice-files/NOT-AA-21-028.html) |Through this NOSI, NIAAA and participating institutes will support research examining policy effects with potential to have meaningful changes in public health. Specific to COVID-19, there is interest in studying effects of changes in alcohol availability during the pandemic and resulting health behaviors and outcomes. Available funding mechanisms are Research Project Grants (R01), Small Grants (R03) and Exploratory/Developmental Research Grants (R21).| |October 5, 2020 through September 8, 2022 (dependent on specific program announcement - R01 or R21)||National Institute on Deafness and Other Communication Disorders (NIDCD)|[Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders (NOT-DC-20-008)](https://grants.nih.gov/grants/guide/notice-files/not-dc-20-008.html) |NIDCD will support research on COVID-19 in relation to the Institute's scientific programs: hearing, balance, taste, smell, voice, speech and language.| |October 14, 2021||National Institute on Drug Abuse (NIDA)|[Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Clinical Trial Not Allowed) (RFA-DA-22-007)](https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-007.html) |NIDA will support mechanistic studies to gain a better understanding of the impact of objective and subjective markers of social inequality on the brain and on the substance abuse trajectory. Topics of interest include distinguishing chronic effects of socioeconomic inequality from acute effects of stressors such as COVID-19 on substance use outcomes.| |Applications may be submitted starting April 1, 2021 and going through March 31, 2022||National Institute on Drug Abuse (NIDA)|[Notice of Special Interest (NOSI): Administrative Supplements for Research on Fentanyl and Derivatives (NOT-DA-21-032)](https://grants.nih.gov/grants/guide/notice-files/NOT-DA-21-032.html) |NIDA is soliciting applications for administrative supplements to ongoing NIDA awards to support research on fentanyl addiction/overdose. Specific to COVID-19, NIDA will fund projects designed to 1) determine drug-drug interactions of fentanyl with medications to treat SARS-CoV-2 infection and 2) understand respiratory effects of SARS-CoV-2 infection among individuals with fentanyl addiction or overdose.| |Applications accepted on rolling basis through March 31, 2022||National Institute on Drug Abuse (NIDA)|[Notice of Special Interest (NOSI) Announcing the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Coronavirus (NOT-DA-21-041)](https://grants.nih.gov/grants/guide/notice-files/NOT-DA-21-041.html) |NIDA will provide additional funding to current grantees for research relevant to COVID-19. The agency is especially interested in funding projects to collect and examine data on risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders (SUDs).| |Deadlines start June 5, 2021 and run through September 7, 2024 depending on the grant mechanism||National Institute on Drug Abuse (NIDA)|[Notice of Special Interest (NOSI): Deciphering the Mosaic of Glia in the Addicted Brain (NOT-DA-21-001)](https://grants.nih.gov/grants/guide/notice-files/NOT-DA-21-001.html) |NIDA will fund projects examining the effects of drug use on the structural and functional diversity and plasticity of glia and non-neuronal cells on nervous system process in the context of drug misuse and substance use disorders (SUD). A specific interest area identified is research to explore the roles of glia in SUD and/or HIV interactions and how they may be influenced by SARS-CoV-2.| |Deadlines start June 5, 2021 and end September 7, 2024 - depending on the chosen grant mechanism (R01, R03 and R21).||National Institute on Drug Abuse (NIDA)|[Notice of Special Interest (NOSI): Effects of Smoking and Vaping on the Risk and Outcome of COVID-19 Infection (NOT-DA-21-011)](https://grants.nih.gov/grants/guide/notice-files/NOT-DA-21-011.html) |The sponsor is interested in supporting research focused on individuals who smoke or vape marijuana and/or tobacco to determine 1) the risk of contracting COVID-19, 2) the effects on asymptomatic COVID-19 infected persons and 3) the course of the COVID-19 infection. This is a reissue of a previous NIDA NOSI - |[NOT-DA-20-084](https://grants.nih.gov/grants/guide/notice-files/NOT-DA-20-084.html). |Deadlines start on May 7, 2021 and go through September 7, 2024.||National Institute on Drug Abuse (NIDA)|[Notice of Special Interest (NOSI): Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorder (NOT-DA-21-018)](https://grants.nih.gov/grants/guide/notice-files/NOT-DA-21-018.html) |NIDA is seeking applications focused on long-term neurocognitive consequences of the current pandemic. Both Research Project Grants (R01) and Exploratory/Developmental Research Grants (R21) are available through this NOSI.| |Deadline dependent on chosen funding mechanism; this NOSI expires September 8, 2024||National Institute on Drug Abuse (NIDA)|[Notice of Special Interest (NOSI): Medical Consequences of Smoking and Vaping Drugs of Abuse in Individuals with HIV and COVID-19 (NOT-DA-21-017)](https://grants.nih.gov/grants/guide/notice-files/NOT-DA-21-017.html) |NIDA is seeking applications exploring the relationship between smoking or vaping marijuana, tobacco, cocaine and/or meth and long-term consequences of this use among individuals with HIV and COVID-19. Research project grants (R01), Small Grants (R03) and Exploratory/Developmental Grants (R21) are offered.| |October 8, 2021||National Institute on Drug Abuse (NIDA)|[Notice of Clarification to PAR-19-064, Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) (NOT-DA-20-062)](https://grants.nih.gov/grants/guide/notice-files/NOT-DA-20-062.html) |NIDA has released a Notice of Clarification for this program announcement, adding an additional priority area concerning risks and outcomes associated with substance use and COVID-19 infection in the general population and among underserved populations. | |Due dates begin with the May 7, 2021 application deadline and extend through September 7, 2024.||National Institute on Drug Abuse (NIDA)|[Notice of Special Interest (NOSI): Telehealth Strategies for Individuals with HIV and Substance Use Disorders (NOT-DA-21-019)](https://grants.nih.gov/grants/guide/notice-files/NOT-DA-21-019.html) |This NOSI offers Research Project Grants (R01), Small Grants (R03) and Exploratory/Developmental Research Grants (R21) to explore and develop telehealth methods and strategies to effectively reach individuals with HIV and substance use disorders.| |November 17, 2021| March 17, 2022 November 17, 2022 February 17, 2023 National Institute on Minority Health and Health Disparities (NIMHD) Other Participating NIH Components: National Institute on Alcohol Abuse and Alcoholism (NIAAA) National Institute on Drug Abuse (NIDA) [Health Services Research on Minority Health and Health Disparities (R01 - Clinical Trial Optional) (PAR-20-310)](https://grants.nih.gov/grants/guide/pa-files/PAR-20-310.html) |The sponsor is encouraging health services research efforts that will directly contribute to the improvement of minority health and/or the reduction of health disparities. Research interests include COVID-19.| Standard NIH deadlines apply; the program announcement expires September 8, 2023 National Institute on Minority Health and Health Disparities (NIMHD) Other Participating Institutes: National Institute on Aging (NIA) National Institute on Drug Abuse (NIDA) National Cancer Institute (NCI) [Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01 - Clinical Trial Optional) (PA-20-172)](https://grants.nih.gov/grants/guide/pa-files/PA-20-172.html) |Will support investigative and collaborative research focused on understanding the long-term effects of natural and/or human-made disasters (to include COVID-19) on health care systems serving health disparity populations in communities in the U.S., including the U.S. territories. NIH-designated health disparity populations include racial and ethnic minorities (Blacks/African Americans, Hispanics/Latinos, American Indians/Alaska Natives, Asians, Native Hawaiians and other Pacific Islanders), sexual and gender minorities, socioeconomically disadvantaged populations, and underserved rural populations.| |Applications due according to NIH standard deadline schedule for R01s (note NIDA offers additional funding mechanisms); this NOSI expires January 8, 2022.| National Institute on Minority Health and Health Disparities (NIMHD) Other Participating NIH Components: National Heart, Lung and Blood Institute (NHLBI) National Institute of Allergy and Infectious Diseases (NIAID) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) National Institute of Dental and Craniofacial Research (NIDCR) National Institute of Mental Health (NIMH) National Institute of Nursing Research (NINR) National Cancer Institute (NCI) National Institute on Drug Abuse (NIDA) [Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake and Implementation among Populations that Experience Health Disparities (NOT-MD-21-008)](https://grants.nih.gov/grants/guide/notice-files/NOT-MD-21-008.html) See [NOT-DA-22-015](https://grants.nih.gov/grants/guide/notice-files/NOT-DA-22-015.html) for specific NIDA interests. NIMHD and partnering Institutes will fund community-engaged research to 1) evaluate intervention strategies to facilitate vaccination (including SARS-CoV-2) uptake in clinical and community contexts, and 2) address the barriers to increasing reach, access and uptake of vaccinations among health disparity populations at high risk and likely to experience vaccine hesitancy. NIDA has announced their participation in this effort and has issued their notice to denote the Institute's specific interest: Research addressing SARS-CoV-2 vaccine implementation among populations with current substance use disorders, particularly those from US health disparity populations. |N/A||National Institutes of Health (NIH)|[Guide Notice of Information Highlighting Harmonization and Data Sharing Expectations for Supplement and Revision Projects Addressing Social, Behavioral, Economic and Health Impacts of the COVID-19 Public Health Emergency (NOT-OD-20-118)](https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-118.html) |NIH has issued a reminder relative to a number of COVID-19 Notices of Special Interest that the agency has \"resources and guidance that will facilitate data harmonization and the development of robust data sharing plans.\"| |Standard NIH deadlines starting February 5, 2022; announcement expires January 8, 2025| National Institutes of Health (NIH) Participating Institutes: National Institute on Minority Health and Health Disparities (NIMHD) National Institute on Drug Abuse (NIDA) National Institute of Mental Health (NIMH) [Effectiveness of School-Based Health Centers to Advance Health Equity (PAR-21-287)](https://grants.nih.gov/grants/guide/pa-files/PAR-21-287.html) |The overall goal is to support research to evaluate how well school-based health centers (SBHCs) work, especially as a safety net care delivery model for youth who lack access to health care on a consistent basis. NIMHD indicates one area of special interest is SBHC's response to long-term health needs of vulnerable youth affected by COVID-19 (e.g., COVID-19 testing, vaccine hesitancy/uptake).| |This opportunity opens for applications starting February 5, 2021 and expires January 8, 2024.||National Institutes of Health (NIH)|[Notice of Special Interest (NOSI): Academy of Finland (AKA) - National Institutes of Health (NIH) Partnership Program (NOT-OD-21-021)](https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-021.html) |Designed to foster expansion of US-Finland biomedical and behavioral research collaborations, this joint research program has at least one COVID-19 related opportunity: To utilize lessons learned from cancer research for COVID-19 treatments.| |Deadlines depend on selected grant mechanism; the NOSI expires on June 8, 2024||National Institutes of Health (NIH) (multiple institutes)|[Notice of Special Interest (NOSI): Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (NOT-OD-21-100)](https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-100.html) |One participating institute, the National Institute of Child Health and Human Development (NICHD), has included an interest in research to understand and improve adherence to COVID-19 preventive measures and/or behaviors.| |Applications will be accepted according to the standard R01 deadline schedule; this NOSI expires May 8, 2023| National Institutes of Health (NIH) Participating NIH Components: National Institute of Minority Health and Health Disparities National Institute of Mental Health National Institute on Drug Abuse Office of Disease Prevention National Institute on Deafness and Other Communication Disorders National Cancer Institute National Library of Medicine National Institute of Arthritis and Musculoskeletal and Skin Diseases [Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities (NOT-MD-20-025)](https://grants.nih.gov/grants/guide/notice-files/NOT-MD-20-025.html) |The purpose of this NOSI is to support investigative and collaborative research focused on developing and evaluating simulation modeling and systems science to understand and address minority health and health disparities across a range of illnesses and conditions including the novel coronavirus pandemic.| |November 8, 2021| National Institutes of Health (NIH) Other Participating Components: National Institute on Aging (NIA) National Eye Institute (NEI) National Institute of Nursing Research (NINR) National Institute on Alcohol Abuse and Alcoholism (NIAAA) National Institute on Drug Abuse (NIDA) National Institute of Mental Health (NIMH) National Institute on Minority Health and Health Disparities (NIMHD) Office of Behavioral and Social Sciences Research (OBSSR) Office of Research on Women's Health (ORWH) [Urgent Award: Social, Behavioral and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed) (PAR-21-213)](https://grants.nih.gov/grants/guide/pa-files/PAR-21-213.html) NIH wishes to fund efforts to advance research on COVID-19, associated mitigation efforts, and how economic disruption affects health-related outcomes including indirect and secondary effects. Studies will leverage existing data from various sources with broad population coverage including underserved and vulnerable individuals. Areas of interest include behavioral/social factors contributing to SARS-CoV-2 transmission and prevention; impacts of various state and local mitigation policies; machine learning algorithms to build better prediction models of COVID-19 transmission; shifts in modes of healthcare delivery (e.g., telemedicine); school closure effects; the pandemic and mental health. This program announcement is soliciting individual population research projects that will then be linked to a Social, Behavioral, and Economic Research on COVID-19 Consortium Coordination Center (SBECCC) to foster collaboration and synergies. NIH issued a [Notice of Change of Award Type](https://grants.nih.gov/grants/guide/notice-files/NOT-AG-21-056.html) on August 25, 2021, changing the titled from Emergency Award to Urgent Award. Among other things, this means NIH will not be providing summary statements or priority scores to principal investigators due to the shortened review period. No set deadline for proposals in response to Dear Colleague Letter Deadline is November 17, 2021 for Ecology and Evolution of Infectious Diseases (EEID) Program |National Science Foundation (NSF)|[Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19)](https://www.nsf.gov/pubs/2020/nsf20052/nsf20052.jsp) NSF encourages investigators to use the Rapid Response Research (RAPID) funding mechanism to address COVID-19 which allows for quick turnaround time to meet project requirements. The first step is to contact the program officer as RAPID proposals require program officer permission to submit. NSF is also encouraging investigators to submit to existing funding opportunities such as the [Ecology and Evolution of Infectious Diseases program (EEID)](https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5269), jointly funded by NSF, NIH, USDA and others; EEID proposals are due November 17, 2021. Proposals for Medium projects may be submitted anytime |National Science Foundation/National Institutes of Health (and a host of other federal agencies)|[Cyber-Physical Systems (CPS)](https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=503286) |Core research areas of this initiative are control, data analytics and machine learning. NIH mentions supporting \"development of CPS research and technology to facilitate medical treatment during a national crisis (e.g., SARS-CoV-2)\" (see Section II.D.3 of the program solicitation for details).| |No set deadline||National Science Foundation (NSF)|[Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-2019)](https://www.nsf.gov/pubs/2020/nsf20055/nsf20055.jsp) NSF is inviting RAPID proposals and supplemental funding requests to existing awards to address COVID-19 challenges through data and/or software infrastructure development activities. Again, program officer permission is required prior to proposal submission. |Proposals accepted anytime||National Science Foundation (NSF)|[Dear Colleague Letter: Sentinel Cells for Surveillance and Response to Emergent Infectious Diseases (Sentinels) (NSF 20-105)](https://nsf.gov/pubs/2020/nsf20105/nsf20105.jsp) |Noting that COVID-19 is unlikely to be the last pandemic in our lifetime, NSF is encouraging use of synthetic biology, cellular engineering, biosensing and immunoengineering as well as other approaches at the intersection of biology and engineering to address the threat of emerging infectious diseases.| |October 1, 2021||National Science Foundation (NSF)|[Predictive Intelligence for Pandemic Phase I: Development Grants (PIPP-Phase I) (NSF 21-590)](https://www.nsf.gov/pubs/2021/nsf21590/nsf21590.htm?WT.mc_id=USNSF_25&WT.mc_ev=click) |This is the first entry into NSF's new initiative focusing on fundamental research and capabilities needed to address grant challenges in infectious disease pandemics prediction and subsequent prevention. The multidisciplinary effort is supported by the Directorates of Computer and Information Science and Engineering; Biological Sciences; Engineering; and Social, Behavioral and Economic Sciences. Phase II will be for Center grants and is expected to be released in Fiscal Year 2023.| November 26, 2021 |Office of Research on Women's Health (ORWH) (within National Institutes of Health)|[Notice of Change: The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional) (RFA-OD-20-168)](https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-168.html) |ORWH has issued a Notice of Change for their ongoing Request for Applications (RFA) to include the influence of sex- and gender-related risk factors associated with COVID-19 disease prevalence, treatment and prevention. Studies examining health-seeking behaviors, access to health care and health care systems as related to COVID-19 are also within scope.| CYCLE 3: Required LOIs due October 5, 2021; invited full applications due January 11, 2022 |Patient-Centered Outcomes Research Institute (PCORI)|[Broad PCORI Funding Announcements: Addressing Disparities; Assessment of Prevention, Diagnosis and Treatment Options; Communication and Dissemination Research; and Improving Healthcare Systems](https://www.pcori.org/funding-opportunities/announcement/broad-pcori-funding-announcements-cycle-3-2021) |PCORI continues to support COVID-19 related research in their Cycle 3 2021 Broad PCORI Funding Program. Designating COVID-19 as a Special Emphasis Area, priority topics are management and survivorship of post-acute COVID-19; impact of COVID-19 on disproportionately affected populations; and impact of COVID-19-related social isolation and loneliness on health outcomes.| |None listed||Pfizer||COVID-19 Vaccine Grants||Through their Global Medical Grants Program, Pfizer is implementing their COVID-19 Vaccine Grants in phases. Current interest areas are: 1) Studies evaluating COVID-19 burden of disease and sero-epidemiological surveys among specific populations; 2) Epidemiological studies evaluating direct and indirect impact, including modeling approaches, of Pfizer's vaccine particularly in specific populations; and 3) Studies measuring the impact of efforts to overcome vaccine hesitancy and enhance vaccine uptake.| Letters of Interest Due September 17, 2021; December 31, 2021; and March 25, 2022 Full Applications Due October 8, 2021; January 21, 2022; and April 15, 2022 RADx-UP* Coordination and Data Collection Center (CDCC) [NIH-funded] [*Rapid Acceleration of Diagnostics for Underserved Populations] |RADx-UP* CDCC Rapid Research Pilot Program||Applicants to this pilot project program should address potential challenges to increased COVID-19 testing in underserved and vulnerable populations in three key areas: 1) Identify and address potential barriers, 2) Align testing to the target population and 3) Test workflow and access. A community-engagement approach should be used.| |November 4, 2021||Russell Sage Foundation|[Pipeline Grants Competition](https://www.russellsage.org/research/funding/pipeline-grants-competition) |The overall goal of this program is to promote diversity in the social sciences including racial, ethnic, gender, disciplinary, institutional nd geographic diversity. It is open to early-career and mid-career tenure-track faculty members, defined by the sponsor as those at the assistant professor level and associate professors at that rank no more than seven years, who are underrepresented in the social sciences. Research efforts should focus on economic mobility among systemic inequities. Projects focused on COVID-19 pandemic consequences within the sponsor's interest areas are encouraged.| |November 10, 2021 for required Letters of Intent; invited full applications are due March 9, 2022||Russell Sage Foundation|[Research Grants](https://www.russellsage.org/how-to-apply/application-deadlines) |The Sage Foundation's core programs for this deadline are Social, Political and Economic Inequality; Future of Work; Behavioral Economics; and Decision Making and Human Behavior in Context. Within any of these core programs, the Foundation is interested in research on the COVID-19 pandemic and the resulting US economic recession, specifically the effects on marginalized individuals and groups and on trust in government and other institutions.| |Required letters of intent are due July 28, 2021; invited full proposals will then be due September 22, 2021.||Tinker Foundation|[Institutional Grants: Education Program](https://tinker.org/information-on-2021-application-cycles/) |The Foundation's overall goal is to support changes to policy and practice that improve the lives of Latin Americans. They have implemented a special initiative related to their Education Program - Ensuring Educational Equity During the Covid-19 Pandemic. | |September 9, 2021||US Department of Education, Institute of Education Sciences (IES)|[National Center for Education Research (NCER) Education Research](https://www.govinfo.gov/content/pkg/FR-2021-06-10/pdf/2021-12173.pdf) |While NCER has not established a separate topic area related to COVID-19, investigators may address COVID-19 related research within one of the specific competition topic areas: Career and Technical Education; Civics Education and Social Studies; Cognition and Student Learning; Early Learning Programs and Policies; Effective Instruction; English Learners; Improving Education Systems; Postsecondary and Adult Education; Literacy; Science, Technology, Engineering and Mathematics (STEM) Education; and Social and Behavioral Context for Academic Learning.| September 9, 2021 |US Department of Education, Institute of Education Sciences (IES)|[National Center for Special Education Research (NCSER) Research to Accelerate Pandemic Recovery in Special Education](https://www.govinfo.gov/content/pkg/FR-2021-06-10/pdf/2021-12173.pdf) |NCSER will fund research projects that directly address COVID-19 pandemic-related problems, issues, programs, policies or practices. Proposed projects should be important to State and local education agencies and have the potential to significantly and rapidly improve student outcomes, providing actionable and timely results to districts "}